SIMTRA
LIVE

Serial Number

98169997

Owner

BAMBOO US BIDCO LLC

Attorney

Salima A. Merani

Filing Date

Sep 7, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SIMTRA Trademark

Serial Number: 98169997

SIMTRA is a trademark filed by BAMBOO US BIDCO LLC on September 7, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

BAMBOO US BIDCO LLC (3 trademarks)

450 Lexington Ave.
New York, NY 10017

Entity Type: 16

Trademark Details

Filing Date

September 7, 2023

Registration Date

Not Registered

Published for Opposition

June 18, 2024

Goods & Services

Dermatologicals; Inhalers for medical purposes, sold filled with pharmaceutical preparations for treating respiratory disorders, infectious disorders, infertility, viruses, diabetes-related conditions, cancer, immune conditions and inflammation; Medicated cosmetics; Medicated dermatological preparations and substances; Pharmaceutical preparations for the treatment and prevention of cancer, infectious diseases, immune disorders, infertility, viruses, blood disorders, genetic disorders, digestive disorders, inflammation, diabetes-related conditions, viral conditions, metabolic conditions, endocrine conditions, musculoskeletal conditions, cardiovascular conditions, cardiopulmonary conditions, genitourinary conditions, sexual dysfunction, hepatological conditions, ophthalmic conditions, respiratory conditions, gastrointestinal conditions, hormonal conditions, degenerative disorders and dermatological conditions; Syringes sold filled with pharmaceutical preparations for treating respiratory disorders, infectious disorders, infertility, viruses, diabetes-related conditions, cancer, immune conditions and inflammation

Custom manufacture of pharmaceuticals; Manufacturing services for others in the field of pharmaceuticals; Providing technical information in the field of pharmaceutical manufacturing

Consulting services in the field of pharmaceutical research and development; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Testing of pharmaceuticals

Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, infectious diseases, immune disorders, infertility, viruses, blood disorders, genetic disorders, digestive disorders, inflammation, diabetes-related conditions, viral conditions, metabolic conditions, endocrine conditions, musculoskeletal conditions, cardiovascular conditions, cardiopulmonary conditions, genitourinary conditions, sexual dysfunction, hepatological conditions, ophthalmic conditions, respiratory conditions, gastrointestinal conditions, hormonal conditions, degenerative disorders, and dermatological conditions; Chemical additives for use in the manufacture of pharmaceuticals; Chemical additives for use in the manufacture of a wide variety of goods; Chemical preparations for scientific purposes; Chemicals for use in industry and science

Pharmaceutical advice; Pharmaceutical compounding services; Providing medical information to manufacturers in the form of reports in the field of manufacturing of active ingredients and scaling

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 28, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jan 27, 2026 EX3G
SOU EXTENSION 3 FILED
Jan 27, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 27, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 8, 2025 EXRA
SOU EXTENSION 2 GRANTED
Aug 7, 2025 EX2G
SOU EXTENSION 2 FILED
Aug 7, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 7, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 4, 2025 EXRA
SOU EXTENSION 1 GRANTED
Feb 4, 2025 EX1G
SOU EXTENSION 1 FILED
Feb 4, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 3, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 13, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 18, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 18, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 29, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 13, 2024 CNSA
ASSIGNED TO EXAMINER
May 3, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 20, 2023 NWOS
NEW APPLICATION ENTERED
Sep 7, 2023 NWAP